Skip to main content
OpenTrials

Clinical trial condition

Dravet Syndrome

Explore clinical trials studying Dravet Syndrome. Study availability and eligibility vary by location and protocol.

41 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Dravet Syndrome trial results

Completed

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

NCT03650452

Conditions
Brain Diseases, Brain Ischemia, CDKL5 deficiency disorder, +35 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Colorado Children's Hospital Aurora, Colorado, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 44 locations
View Trial Details
Completed

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

NCT05626634

Conditions
Brain Diseases, CDKL5 deficiency disorder, Central Nervous System Diseases, +23 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rancho Los Amigos National Rehabilitation Center (RLANRC) Downey, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Northwest Florida Clinical Research Group Gulf Breeze, Florida, United States
View all 28 locations
View Trial Details
Completed

A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

NCT03936777

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Ep0215 107 Tucson, Arizona, United States
  • Ep0215 144 Los Angeles, California, United States
  • Ep0215 108 San Diego, California, United States
  • Ep0215 101 San Francisco, California, United States
View all 71 locations
View Trial Details
Completed

An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome

NCT02823145

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +9 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Center for Neurosciences - Tucson Tucson, Arizona, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
View all 67 locations
View Trial Details
Completed

An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome

NCT04442295

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +5 more
Locations
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 18 locations
View Trial Details
Completed

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

NCT05364021

Conditions
Brain Diseases, CDKL5 deficiency disorder, Central Nervous System Diseases, +22 more
Locations
  • University of Arizona - Health Sciences Center Tucson, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rancho Los Amigos National Rehabilitation Center (RLANRC) Downey, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 34 locations
View Trial Details

Related conditions